Patents Assigned to Vanderbilt University
  • Patent number: 11591443
    Abstract: Disclosed herein are crosslinked polycarbonates, composition thereof and methods thereof. The crosslinked polycarbonates can be prepared from allyl or epoxy polycarbonates. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    Type: Grant
    Filed: March 17, 2021
    Date of Patent: February 28, 2023
    Assignee: Vanderbilt University
    Inventors: Eva M. Harth, David M. Stevens
  • Patent number: 11592286
    Abstract: System and methods are provided for characterizing an internal surface of a lens using interferometry measurements. Sphere-fitting a distorted radius determines distorted pathlengths. Ray-tracing simulates refraction at all upstream surfaces to determine a cumulative path length. A residual pathlength is scaled by the group-index and rays are propagated based on the phase-index. After aspheric surface fitting, a corrected radius is determined. To estimate a glass type for the lens, a thickness between focal planes of the lens surfaces is determined using RCM measurements. Then, for both surfaces, the surface is positioned into focus, interferometer path length matching is performed, a reference arm is translated to stationary phase point positions for three wavelengths to determine three per-color optical thicknesses, and ray-tracing is performed. A glass type is identified by minimizing an error function based on optical parameters of the lens and parameters determined from known glass types from a database.
    Type: Grant
    Filed: December 3, 2021
    Date of Patent: February 28, 2023
    Assignee: Vanderbilt University
    Inventors: Yuankai Tao, Mohamed T. El-Haddad
  • Patent number: 11585881
    Abstract: In vivo methods for non-invasively imaging (or measuring without spatial localization) of neuro-electro-magnetic oscillations are achieved by a pulse sequence of radio frequency (RF) irradiation and magnetic field gradients. These RF and gradient pulses create an intermolecular zero-quantum coherence (iZQC), the frequency of which is: 1) controlled by one or more magnetic field gradients; and 2) made to match the frequency of the targeted neuro-electro-magnetic oscillation.
    Type: Grant
    Filed: October 16, 2020
    Date of Patent: February 21, 2023
    Assignee: VANDERBILT UNIVERSITY
    Inventor: Daniel Gochberg
  • Patent number: 11588418
    Abstract: Disclosed herein are energy harvesting devices and methods of making and use thereof. The energy harvesting devices can efficiently harvest energy for motions at a frequency of 5 Hz or less.
    Type: Grant
    Filed: August 8, 2018
    Date of Patent: February 21, 2023
    Assignee: Vanderbilt University
    Inventors: Cary L. Pint, Nitin Muralidharan
  • Patent number: 11577079
    Abstract: The present disclosure relates to the treatment of patients with Parkinson's Disease using subthalmic nucleus deep brain stimulation to a specific region of the brain. By positioning the electrode in the margin of the dorsal-lateral and anterior region of the subthalamic nucleus, improved benefits are obtained.
    Type: Grant
    Filed: March 27, 2018
    Date of Patent: February 14, 2023
    Assignee: VANDERBILT UNIVERSITY
    Inventors: David Charles, Mallory Hacker, Peter Konrad
  • Patent number: 11571686
    Abstract: The present disclosure provides a method that embodies a simple and effective route to remove homogeneous catalysts from solutions wherein NMR/MRI signal amplification by reversible exchange (SABRE) or parahydrogen-induced polarization (PHIP) is performed. A method for recovering a homogeneous SABRE/PHIP catalyst for reuse is also described.
    Type: Grant
    Filed: February 17, 2020
    Date of Patent: February 7, 2023
    Assignees: Board of Trustees of Southern Illinois University, Vanderbilt University, The Regents of the University of California
    Inventors: Boyd M. Goodson, Eduard Y. Chekmenev, Igor V. Koptyug, Kirill V. Kovtunov, Roman V. Shchepin, Bryce E. Kidd, Jonathan Gesiorski, Max E. Gemeinhardt, Danila A. Barskiy
  • Patent number: 11571455
    Abstract: Disclosed are compositions and methods for treating inflammation including its end-stage sepsis and conditions mediated by inflammation such as liver apoptosis and cirrhosis, thrombocytopenia, hypoglycogenemia, hyperglycemia, and hypertriglyceridemia. In one aspect, the compositions and methods disclosed herein can also be used to enhance clearance of microbes from infected tissues, organs, or systems in a subject. Also disclosed herein are compositions and methods for reducing levels of stress responsible transcription factors and metabolic transcription factors in a cell in a subject with microbial, allergic, autoimmune, metabolic, and posttraumatic inflammation.
    Type: Grant
    Filed: May 29, 2020
    Date of Patent: February 7, 2023
    Assignee: VANDERBILT UNIVERSITY
    Inventors: Jack Jacek Hawiger, Jozef Zienkiewicz, Danya Liu
  • Patent number: 11565256
    Abstract: Microfluidic systems, pumps, valves and applications of the same are provided. The microfluidic system may be a pump or a valve having a fluidic chip and an actuator controlling the opening and closing of the fluidic channel in the fluidic chip. The actuator may be disposed to tilt from the fluidic chip, forming a tilted-rotor peristaltic pump. Alternatively, the actuator may be a rolling ball actuator, and different fluidic chips may be used in different applications. For example, the fluidic chip may be a spiral pump chip having spiral channels, a rotary peristaltic pump chip having multiple output channels, or a multi-port valve chip having one port interconnected with multiple different ports. An analytical valve chip may switchably interconnect bioreactor and rinse/calibration input channels to sensor and waste output channels. The actuator of a random-access valve can move from one valve position to another without opening or closing intermediate ones.
    Type: Grant
    Filed: June 29, 2020
    Date of Patent: January 31, 2023
    Assignee: VANDERBILT UNIVERSITY
    Inventors: Ronald S. Reiserer, David K. Schaffer, Philip C. Samson, Dmitry A. Markov, Michael Geuy, Lisa J. McCawley, John P. Wikswo
  • Patent number: 11565112
    Abstract: The present disclose generally relates to systems and methods for active titration of one or more cranial or peripheral nerve stimulators to treat obstructive sleep apnea. The active titration can be accomplished in an automated fashion by a closed-loop process. The closed-loop process can be executed by a computing device that includes a non-transitory memory storing instructions and a processor to execute the instructions to perform operations. The operations can include defining initial parameters for the one or more cranial or peripheral nerve stimulators for a patient; receiving sensor data from sensors associated with the patient based on a stimulation with the one or more cranial or peripheral stimulators programmed according to the initial parameters; and adjusting the initial parameters based on the sensor data.
    Type: Grant
    Filed: August 1, 2019
    Date of Patent: January 31, 2023
    Assignee: VANDERBILT UNIVERSITY
    Inventor: David T. Kent
  • Publication number: 20230001400
    Abstract: The present disclosure provides a method that embodies a simple and effective route to remove homogeneous catalysts from solutions wherein NMR/MRI signal amplification by reversible exchange (SABRE) or parahydrogen-induced polarization (PHIP) is performed. A method for recovering a homogeneous SABRE/PHIP catalyst for reuse is also described.
    Type: Application
    Filed: February 17, 2020
    Publication date: January 5, 2023
    Applicants: Board of Trustees of Southern Illinois University, Vanderbilt University, The Regents of the University of California
    Inventors: Boyd M. Goodson, Eduard Y. Chekmenev, Igor V. Koptyug, Kirill V. Kovtunov, Roman V. Shchepin, Bryce E. Kidd, Jonathan Gesiorski, Max E. Gemeinhardt, Danila A. Barskiy
  • Patent number: 11534321
    Abstract: In one embodiment, the orthotic device can include a powered hand portion, a switching element, and a controller. The wearer can interact with the switching element to generate input signals for adjusting an operation of the powered hand portion. The controller can receive the input signals and generate control signals to accordingly adjust the operation of the powered hand portion. In some embodiments, a powered hand portion can be comprised of a plurality of linkages and at least one powered actuator to assist with an opening and closing of the hand portion. The plurality of linkages can be operated by at least one electric motor with quick-connect elements to link onto fingers of a user. In some embodiments, an electrically-actuated clutch mechanism can be affixed to an upper arm section and a lower arm section of an orthotic device. The clutch mechanism can be configured into different positions.
    Type: Grant
    Filed: May 25, 2018
    Date of Patent: December 27, 2022
    Assignee: Vanderbilt University
    Inventors: Michael Goldfarb, Benjamin William Gasser, Daniel Alvin Bennett
  • Patent number: 11524994
    Abstract: The present disclosure is directed to antibodies binding to human respiratory syncytial virus F protein, including both neutralizing and non-neutralizing antibodies, and methods for use thereof.
    Type: Grant
    Filed: December 18, 2017
    Date of Patent: December 13, 2022
    Assignee: VANDERBILT UNIVERSITY
    Inventors: James E. Crowe, Jr., Jarrod Mousa
  • Patent number: 11519859
    Abstract: Provided are novel rhodol-based compounds, the preparation method thereof, and use thereof in Tl+ flux assays. The fluorescent thallium ion sensor compounds have a rhodol fluorophore attached to an amino dicarboxylic acid metal binding moiety. The compounds are prepared in the “pro-dye” form, with the rhodol oxygen and the carboxylic acids of the metal binding unit masked by protecting groups. The disclosed compounds may be used as more red-shifted and less pH-sensitive variants of Thallos.
    Type: Grant
    Filed: April 9, 2019
    Date of Patent: December 6, 2022
    Assignee: Vanderbilt University
    Inventors: Charles David Weaver, Brendan F. Dutter, Gary A. Sulikowski
  • Publication number: 20220380442
    Abstract: The present disclosure is directed to antibodies binding to and neutralizing hantavirus and methods for use thereof.
    Type: Application
    Filed: November 10, 2020
    Publication date: December 1, 2022
    Applicant: Vanderbilt University
    Inventor: James E. CROWE, Jr.
  • Patent number: 11504053
    Abstract: A mucosal impedance measuring apparatus detects and measures a condition of mucosa. The mucosal impedance measuring apparatus includes a catheter comprising a tube, impedance sensing electrodes on an exterior surface of the catheter, a balloon mounted on the tube in which the balloon is capable of inflation and deflation, and an impedance measuring system. The impedance measuring system is adapted to measure a pressure-regulated impedance measurement of the mucosa that is indicative of the condition of the mucosa when the balloon is inflated and the impedance sensing electrodes direct an electric current through mucosa while the balloon is pressed against the mucosa.
    Type: Grant
    Filed: May 6, 2019
    Date of Patent: November 22, 2022
    Assignees: Diversatek Healthcare, Inc., Vanderbilt University
    Inventors: Jerry E. Mabary, Michael F. Vaezi, Thomas D. Stuebe
  • Publication number: 20220356312
    Abstract: A non-woven carbon fiber reinforced thermoplastic (CFRTP) composite object is formed by the variable frequency microwave (VFM) irradiation of a mixed fiber sheet of thermoplastic fibers, carbon fibers and wavy carbon nanotubes (CNTs). The mixed fiber sheets are prepared from a slurry of the thermoplastic fibers, carbon fibers, and wavy CNTs such that the wavy CNTs contact the carbon fibers and thermoplastic fibers. Upon irradiation with VFM radiation, the wavy CNTs generate heat and transfer the heat to the thermoplastic fibers, causing melting of the thermoplastic to form the matrix of the CFRTP composite object. The mixed fiber sheets can be combined alone or with other sheets to form laminar composites that are molded into objects and heated by VFM irradiation.
    Type: Application
    Filed: May 4, 2021
    Publication date: November 10, 2022
    Applicants: Toyota Motor Engineering & Manufacturing North America, Inc., Vanderbilt University
    Inventors: Yuyang Song, Umesh N. Gandhi, Piran R. Kidambi
  • Patent number: 11492644
    Abstract: Expression of exogenous SNAI2, EYA1 and SIX1 genes in a cell, tissue or organ not normally having nephron progenitor activity, induces or re-programs that cell to have or subsequently develop nephron progenitor activity. Nephron progenitors induced 5 by expression of SNAI2, EYA1 and SIX1 may be used for the production of nephron cells and tissues that are useful in treatment of kidney disorders, kidney regeneration, kidney transplantation, bioprinting and nephrotoxocity testing.
    Type: Grant
    Filed: May 24, 2018
    Date of Patent: November 8, 2022
    Assignees: MURDOCH CHILDRENS RESEARCH INSTITUTE, VANDERBILT UNIVERSITY, THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OE VETERANS AFFAIRS
    Inventors: Melissa Little, Jessica Vanslambrouck, Lauren Woodard, Matthew Wilson
  • Patent number: 11493751
    Abstract: An optical relay comprises a first scan mirror configured to receive an input optical beam, and to reflect the input optical beam as a first intermediate optical beam; a telecentric mirror configured to receive the first intermediate optical beam, and to reflect the first intermediate optical beam as a second intermediate optical beam; a second scan mirror configured to receive the second intermediate optical beam, and to reflect the second intermediate optical beam as an output optical beam; and a lens system disposed between the telecentric mirror and the first and second scan mirrors, such that the first intermediate optical beam and the second intermediate optical beam pass through the lens system. The optical relay may be a component of an optical system which further includes an optical engine.
    Type: Grant
    Filed: January 23, 2020
    Date of Patent: November 8, 2022
    Assignee: Vanderbilt University
    Inventors: Yuankai Tao, Joseph D. Malone
  • Patent number: 11484032
    Abstract: In one aspect, the invention relates to chemical modulators of insect olfactory receptors. In particular, compounds and compositions are provided that can inhibit sensory (e.g., host targeting) functions in airborne insects such as mosquitos. Methods of employing such agents, and articles incorporating the same, are also provided. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    Type: Grant
    Filed: July 31, 2020
    Date of Patent: November 1, 2022
    Assignee: VANDERBILT UNIVERSITY
    Inventors: Laurence Zwiebel, Gregory M. Pask, David C. Rinker, Ian M. Romaine, Gary A. Sulikowski, Paul R. Reid, Alex G. Waterson, Kwangho Kim, Patrick L. Jones, Robert W. Taylor
  • Patent number: 11471444
    Abstract: Thromboxane A2 receptor antagonists, such as ifetroban, inhibit solid tumor metastasis. The formation of surface and microscopic lung metastases are inhibited. Thromboxane A2 receptor antagonists can inhibit the tumor metastasis process without affecting the growth or development of a primary tumor.
    Type: Grant
    Filed: November 29, 2018
    Date of Patent: October 18, 2022
    Assignee: Vanderbilt University
    Inventors: Jill M. Pulley, Robert R. Lavieri